Gam-COVID-Vac
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, romanized: Gam-KOVID-Vak), trade-named Sputnik V, is a COVID-19 vaccine created by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health.[1][2][3]
Gam-COVID-Vac has been approved for distribution in Russia.[1][4][5]
Gam-COVID-Vac Media
Sputnik V vaccination certificate issued in Moscow Gostiny Dvor vaccination point
Pharmaceutical company União Quimica started production of Sputnik V in Brazil in January 2021.[source?]
Package and Vial for the first dose
Sputnik V, efficacy for different conditions. The error bars indicate the confidence interval containing the efficacy with 95% probability.
President Putin's meeting with government members, on 11 August 2020 via videoconference, at which he announced a conditionally registered vaccine against COVID-19
Medical worker in Moscow with the vaccine
Vaccination of military personnel and civilian specialists of the Northern Fleet with the second component of the drug "Gam-COVID-Vac" ("Sputnik V")
In dark green are the countries that approved Sputnik V vaccine against COVID-19. In light green are the countries that have shown interest in obtaining the vaccine. Light blue indicates current or future producers and dark blue the country origin of vaccine design (Russia).
.jpg)
_(3).jpg)
_%E2%80%93_(01).jpg)
.jpg)
References
- ↑ 1.0 1.1 Russia's fast-track coronavirus vaccine draws outrage over safety. Nature 584 (7821) (August 2020). p. 334–335. doi:10.1038/d41586-020-02386-2.
- ↑ "Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. 11 August 2020. https://www.sciencemag.org/news/2020/08/russia-s-approval-covid-19-vaccine-less-meets-press-release. Retrieved 13 August 2020.
- ↑ "Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?" (in en). Reuters. 11 August 2020. https://www.reuters.com/article/us-health-coronavirus-vaccine-russia-exp/scientists-ask-without-trial-data-how-can-we-trust-russias-covid-vaccine-idUSKCN2571TL. Retrieved 11 August 2020.
- ↑ Covid-19: Russia approves vaccine without large scale testing or published results. BMJ 370 (August 2020). p. m3205. doi:10.1136/bmj.m3205.
- ↑ COVID-19 vaccines: early success and remaining challenges (in English). Lancet 396 (10255) (September 2020). p. 868–869. doi:10.1016/S0140-6736(20)31867-5.
